Introduction
Tuberculosis (TB) is a major public health problem, and its losis infection in the lungs of infected mice (5,6). As mice deficient in CD8 ϩ T cells are unable to adequately control incidence is increasing due to the HIV/AIDS pandemic and the emergence of multidrug-resistant strains of Mycobacterium tuberculosis infection (7), these data suggest that CD8 ϩ T cells may play an important role in the generation of tuberculosis. Several lines of evidence have demonstrated that protective immunity against infection with M. tuberculosis protective immunity against M. tuberculosis infection. Presently little is known concerning the mechanisms of and M. bovis bacillus Calmette-Guerin (BCG) is essentially mediated by MHC class II-restricted CD4 ϩ T cells (1, 2) . This induction and the specificity of CD8 ϩ T cells during mycobacterial infections. In contrast to viruses which replicate in cell subset represents a major source of cytokines activating macrophage bactericidal effector functions such as IFN-γ, the cytosol of infected cells, M. tuberculosis appears to remain in the endosomal compartment. The presentation of therefore contributing to the containment of infection (3, 4) . Recently, it has been reported that CD8 ϩ T cells of T h 1 mycobacterial peptides to CD8 ϩ T cells has been reported in association with MHC class I (8,9), CD1 (10,11) and nonphenotype accumulate during the early phase of M. tubercu-classical MHC class Ib molecules (12), but the mechanisms selected with 5-bromodeoxyuridine in a TK -cell line, 143B. The recombinant VVWR was screened with DNA dot-blots by which mycobacterial antigens escape the phagosome and enter these presentation pathways are still unclear. The and immunofluorescence. Following three rounds of plaque purifications, recombinant VV was expanded and viral stocks antigen specificity of mycobacteria-reactive CD8 ϩ T cells in M. tuberculosis-infected humans (8) and mice (9) is also were prepared by ultracentrifugation through a sucrose cushion. The pBCB06 plasmid and a control VVWR expressing poorly understood. Although the presence of epitope-specific CD8 ϩ T cells was clearly demonstrated in mice immunized hemagglutinin of influenza virus (VVWR-PR8/HA6) were provided by Dr D. Boyle (CSIRO, Geelong, Australia). with mycobacterial antigen-expressing plasmid DNA, CD8 ϩ T cells with specificity for the same epitopes were not detected
Western blot analysis in BCG-or M. tuberculosis-infected mice (13,14). These observations suggest that the presentation of mycobacterial Virus-infected 143B cell lysates were separated by SDS-PAGE (15% gel). The proteins were then transferred to a antigens to CD8 ϩ T cells is relatively inefficient, possibly because of the low level of endogenous expression of antigens nitrocellulose membrane and detected with an anti-MPT64 rabbit serum followed by a horseradish peroxidase-conjugin infected antigen-presenting cells (APC). Therefore, the study of CD8 ϩ T cells responses to mycobacterial antigens ated donkey anti-rabbit IgG (Amersham, Little Chalfont, UK). The reaction was developed using an enhanced chemiluminmay be facilitated by the use of viral expression vectors.
In the present work, we have characterized the CD8 ϩ escence reagent (Pierce, Rockford, IL). For inhibition experiments, TK -143B cells were infected with VVWR-64 in the T cells response induced by a model mycobacterial antigen when expressed by a recombinant vaccinia virus (VV). The presence of tunicamycin (1 µg/ml) (Sigma, St Louis, MO) for 24 h. proteins secreted by mycobacteria in short-term culture filtrate are major antigens leading to protective immunity against
In vitro stimulation of effectors and generation of CD8 ϩ M. tuberculosis via the activation of both CD4 ϩ and CD8 ϩ T cell lines T cells (15, 16) . One of these secreted antigens, MPT64, was selected as it is commonly recognized by TB patients and Mice were infected i.v. with 10 7 p.f.u. of recombinant VV or 5ϫ10 6 c.f.u. of BCG. Between 6 and 8 weeks later, splenocytes their contacts (17), and elicits a strong delayed-type hypersensitivity response in guinea pigs (18). Immunization of mice (5ϫ10 6 /ml) from infected mice were re-stimulated with peptides (5 µM) in complete RPMI (RPMI supplemented with with VV expressing MPT64 (VVWR-64) allowed us to identify a novel H-2D b -restricted peptide contained within MPT64 10% FBS, 2 mM L-glutamine, 10 mM HEPES, 0.5 µM 2-mercaptoethanol, 100 U/ml penicillin and 100 µg/ml strepto-(MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] ). We found that a cytotoxic T lymphocyte (CTL) response specific to MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] was generated in mice mycin) in 24-well plates. Recombinant murine IL-2 (10 U/ml) (Boehringer Mannheim, Mannheim, Germany) was added following infection with BCG, although to a lower extent than with VVWR-64. Importantly, dendritic cells (DC) infected with 24 h later. To maintain MPT64 peptide-specific CD8 ϩ T cell lines, 5ϫ10 4 /well T cells were re-stimulated weekly with 5ϫ10 6 / BCG in vitro activated MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] -specific CD8 ϩ T cells in a MHC class I-restricted context. These results provide well irradiated syngeneic splenocytes and 5 µM peptide in the presence of IL-2. evidence that MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] is presented to CD8 ϩ T cells during mycobacterial infections, but suggest that 51 Cr-release assay MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] -specific CD8 ϩ T cell clones are generated in vivo at low frequencies.
EL-4 (H-2 b ) target cells were pulsed with peptides (20 µM) and labeled with 100 µCi 51 Cr (NEN Life Sciences, Boston, MA) for 1.5 h at 37°C. Labeled target cells were then incubated Methods with effector cells at various ratios (E:T) for 4 h. The radioactivity released in culture supernatants was measured with Mice a γ-counter (Packard, ACT, Australia). The total release was C57BL/6 female mice were supplied by Animal Resources determined by Triton X-100 lysis of labeled target cells. Centre (Perth, Australia) and maintained as previously
The percentage of specific lysis was calculated as follows: described (5).
(experimental -spontaneous release)/(total -spontaneous release)ϫ100. Spontaneous release was always Ͻ20% of the Bacteria and synthetic peptides total release. For blocking experiments, mAb were added to BCG (Tokyo strain), which expresses and secretes MPT64 the target cells 30 min before incubating with effector cells. protein (19), was obtained from ATCC (Rockville, MD). The mAb, FACS staining and flow cytometry analysis predicted MPT64 peptides and control peptides were purchased from Research Genetics (Huntsville, AL). Sequence
The following mAb were used for flow cytometry analysis or predictions were based on a scheme developed by Dr in inhibition experiments: culture supernatant of mAb specific K. Parker (20) .
for CD86 (B7.2) (clone GL1 TriColor-conjugated anti-CD8α (clone CT-CD8a) and isotype control mAb were obtained from Caltag. Procedures for staining and flow cytometry analysis have been previously described (5) . For detection of intracellular cytokines, CD8 ϩ T cells specific for MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] were cultured with EL4 pulsed with either MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] or a control peptide for 4 h at 37°C in the presence of Brefeldin A (10 µg/ml) (Sigma). Unpulsed EL4 cells were included as control cells. The intracellular expression of cytokines in CD8 ϩ T cells was then detected by flow cytometry.
Co-culture of infected bone marrow-derived DC with CD8 ϩ T cell lines
Bone marrow-derived DC were generated and infected with BCG as previously described (21) . For infection with VVWR-64, DC were infected with the virus at a m.o.i. of 10:1 for 1 h at 37°C. After washing, infected DC were incubated 16 h at 37°C before assay. Eleven days after re-stimulation, 10 5 MPT64 190-198 -specific CD8 ϩ T cells were cultured with 10 5 DC infected with BCG or VVWR-64. MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] peptidepulsed or untreated DC were included as controls. Production of IFN-γ in culture supernatants after 48 h was analyzed by ELISA. For inhibition assays, culture supernatants from hybridomas producing mAb specific for I-A, H-2D b or purified anti-CD1d mAb (5 µg/ml) were added to DC cultures at the time of incubation with MPT64 190-198 -specific CD8 ϩ T cells.
IFN-γ ELISPOT
Splenocytes isolated from mice infected with BCG or VVWR-64 were stained with a FITC-conjugated anti-CD8 mAb (clone 53-6.7; PharMingen) for 10 min at 4°C. FITC-stained cells were then positively selected using anti-FITC microbeads (Miltenyi Biotec, Bergish Gladbach, Germany) and a Midi-MACS separation column (Miltenyi Biotec) according to the manufacturer's instructions. For the ELISPOT assays, 96-well nitrocellulose plates (Millipore, Bedford, MA) were coated with AN18 mAb overnight at 4°C. After blocking, serial dilutions of purified CD8 ϩ T cells were added to irradiated syngeneic splenocytes (5ϫ10 5 /well) with or without peptides (5 µM) for from VVWR-64-infected mice to MPT64-derived peptides. Cytotoxicity was assessed on peptide-pulsed target at an E:T ratio of 100:1. No peptide-specific lysis was detected in unimmunized or in VVWR-PR8/
Results

HA6-infected mice (data not shown).
Construction of VVWR-64
In order to generate high levels of endogenous expression of MPT64 and to enhance the protein delivery to the MHC class VVWR-64 infected cells expressed both glycosylated and non-glycosylated forms of MPT64. I presentation pathway, a recombinant VV expressing MPT64 was constructed. Western blot analysis performed on lysates
Infection of mice with VVWR-64 induces cytotoxic and IFN-γ of TK -143B cells infected with the recombinant viruses
responses to a MPT64-derived peptide, MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] confirmed that a 23 kDa mycobacterial protein corresponding to the native MPT64 from BCG was expressed (Fig. 1A) . In
The ability of VVWR-64 to induce a CTL response to MPT64 was tested using a panel of 9mer MPT64 peptides with addition, a protein of higher mol. wt was also detected. When TK -143B cells were infected with VVWR-64 in the presence sequences predicted to bind to H-2K b or D b alleles (Table  1) . Splenocytes from mice infected with VVWR-64 were reof tunicamycin, an inhibitor of N-linked glycosylation, the formation of this band was inhibited, demonstrating that stimulated in vitro with the selected peptides for 6 days. The analysis confirmed that the MPT64 190-198 -specific CTL were of the CD8 ϩ phenotype (Fig. 2C) . The specific lysis of EL4 cells pulsed with MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] was inhibited by an anti-D b mAb (Fig. 2D) . Therefore, the cytolytic and IFN-γ-producing CD8 ϩ T cell line recognized MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] peptide in association with H-2D b .
MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] -specific CTL can be detected in BCG-infected mice following repeated stimulation
To investigate whether MPT64-specific CTL were generated in vivo following BCG infection, splenocytes from BCGinfected mice were stimulated with the same panel of MPT64 peptides and their cytotoxic activity to peptide-pulsed target cells was tested.
No cytolytic activity could be demonstrated with any of the MPT64 peptides after 6 days of in vitro stimulation (Fig. 3A) . In order to increase the sensitivity of detection of MPT64-specific CD8 ϩ T cells, an IFN-γ ELISPOT assay was performed with CD8 ϩ T cells purified by the MACS separation system. By this method, CD8 ϩ T cell preparation purity was Ͼ93% (data not shown). In accordance with the cytotoxicity assays, a potent IFN-γ response was observed with CD8 ϩ T cells isolated from spleens of VVWR-64-infected mice, but not from BCG-infected animals (Fig. 3B) . CD8 ϩ T cell reactivity to peptide P38 225-234, another H-2D b -restricted CD8 ϩ T cell epitope contained in the 38 kDa mycobacterial protein (14) , was also tested. The production of IFN-γ by activity was assessed. After 4 weeks of stimulation, cytotoxic activity to the MPT64 190-198 peptide was detected (Fig. 4) .
No activity was observed with the other four peptides. Figure 5 compares the IFN-γ production levels in co-cultures of the MPT64 190-198 -specific CD8 ϩ T cell line and of BCG-infected, VVWR-64-infected or MPT64 190-198 -pulsed DC. BCG-infected DC activated CD8 ϩ T cells to produce IFN-γ, demonstrating cytolytic activity was then tested in a standard 51 Cr-release assay, using peptide-pulsed EL4 cells as targets. Figure 1(B) that MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] is processed by DC following BCG infection. However, T cell activation with BCG-infected DC, as measured shows that splenocytes from VVWR-64-infected mice showed reactivity to one of the peptides, MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] .
by IFN-γ production, was less potent than with VVWR-64-infected DC or peptide-pulsed DC. The effector functions and phenotype of MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] specific CTL were characterized after three or four rounds of MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] presentation by BCG-infected DC is MHC class weekly stimulation. These CTL efficiently lysed MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] I restricted peptide-pulsed EL4 cells ( Fig. 2A) and rapidly produced IFN-γ, but no IL-4, following re-exposure to the peptide (Fig. 2B) .
BCG infection of DC is known to induce cell maturation (21) , as shown by the up-regulation of MHC class II and coThese effects were specific to the MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] peptide, since no cytolytic activity or cytokine production were observed stimulatory B7-2 molecules (Fig. 6A) . In order to elucidate the pathway of MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] presentation, expression of MHC following re-stimulation with EL4 cells alone, or with EL4 pulsed with a control peptide (data not shown). Flow cytometry class I and CD1d molecules on BCG-infected DC was ana- 
Discussion
CD8 ϩ T cells appear to play a role in the control of both human lyzed by flow cytometry (Fig. 6A) . BCG-induced maturation and murine TB (22,23). Although mycobacteria-reactive CD8 ϩ of DC was associated with the up-regulation of MHC class I T cells can be detected in BCG-infected mice, BCG-vaccinmolecules, whereas the expression of CD1d was not modified. ated individuals and TB patients (8, 24, 25) , only few CD8 ϩ T When BCG-infected DC were incubated with a mAb blocking cell epitopes have been identified to date (14, 26, 27) . In the H-2D b molecule and co-cultured with a MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] -specific present study, we have defined a novel H-2D b -restricted CD8 ϩ T cell line, IFN-γ production was inhibited (Fig. 6B) .
epitope within MPT64, a major mycobacterial antigen secreted In contrast, anti-I-A and anti-CD1d blocking mAb did not by BCG and M. tuberculosis. The observations that CD8 ϩ modify DC-mediated T cell activation, demonstrating that CTL recognizing MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] are generated in BCG-infected MPT64 190-198 presentation on BCG-infected DC is MHC class mice and that BCG-infected DC activate the MPT64 190-198 -specific CD8 ϩ T cell line strongly suggest that this epitope is I-restricted.
with Brefeldin A, an inhibitor of transport through the Golgi apparatus (8, 24) . Taken together, these data suggest that the alternative MHC class I presentation pathway may operate within mycobacteria-infected APC.
The numbers of MPT64-specific CTL and IFN-γ-secreting CD8 ϩ T cells was significantly lower in BCG-infected than in VVWR-64-infected mice. Similar discrepancies in the frequency of mycobacterial antigen-specific CD8 ϩ T cells were observed when comparing DNA-vaccinated to mycobacteriainfected animals (13, 14) . BCG-infected DC were less efficient at presenting the MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] peptide to specific CD8 ϩ T cells than VVWR-64-infected DC. Therefore, the low frequency of reactive CD8 ϩ T cells generated during mycobacterial infections may be related to the capacity of mycobacteria-infected DC to present antigens via the MHC class I presentation pathway. Several reasons may account for this. First, the subcellular location of mycobacteria favors the processing of antigens via the MHC class II presentation pathway and the subsequent activation of CD4 ϩ T cells. Second, there is evidence demonstrating that antigen presentation to CD8 ϩ T cells via the non-classical exogenous DC are major APC for the generation of primary T cell responses against microbial infections (35) . Infection of DC with BCG or M. tuberculosis leads to direct cell activation, with up-regulated expression of T cell co-stimulatory and processed and presented by host APC during mycobacterial infections. As for other reported mycobacterial epitopes, the MHC class II molecules (21, 36) . Infected DC therefore have an increased ability to prime naive CD4 ϩ T cells against presence of cytolytic CD8 ϩ T cells specific to MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] could not be demonstrated directly ex vivo and required internalized antigens. The expression of MHC class I molecules is also augmented following BCG or M. tuberculosis repeated in vitro stimulation (26) (27) (28) , suggesting that mycobacteria-specific CD8 ϩ CTL are primed during infection at a infection ( Fig. 6) (21, 36) , suggesting that DC also play a role in the priming of CD8 ϩ T cells against microbial antigens. very low frequency. This raises the question of how CD8 ϩ T cell responses of such low amplitude can participate in DC are able to prime naive CD8 ϩ T cells in vitro when pulsed with mycobacterial peptides. Our finding that the protective immunity against M. tuberculosis infection. The possibility remains that mycobacteria-specific CD8 ϩ T cells MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] peptide is presented by DC following infection with BCG and that MPT64 [190] [191] [192] [193] [194] [195] [196] [197] [198] presentation results in the with a phenotype other than cytolytic or IFN-γ producing are also generated. Indeed, it has been shown that the number activation of specific CD8 ϩ T cells, further supports the evidence that DC are critical APC for the generation of specific of IL-4-producing CD8 ϩ T cells increased in the peripheral blood of patients with cavitary TB (29) . Moreover, CD8 ϩ T cells CD8 ϩ T cell responses against mycobacterial antigens. CD8 ϩ T cells reacting to mycobacterial antigens presented may exert a protective role against mycobacterial infections by regulating the effector functions of CD4 ϩ T cells (30, 31) .
by CD1 molecules of group I (CD1a, b and c) are able to lyse M. tuberculosis-infected macrophages and therefore It is still unclear how mycobacteria that reside primarily within phagosomes of infected macrophages can elicit a contribute to the control of mycobacterial infection in human (10). Group II CD1 molecules in human, which are homologous CD8 ϩ T cell response. Indeed, the classical MHC class I presentation pathway actively transports peptides generated to the murine CD1d, have been less extensively studied and there is no evidence to date that they also present by degradation of endogenous proteins from the cytosol to the endoplasmic reticulum where they bind to MHC class I mycobacterial antigens. The recognition of M. tuberculosisinfected macrophages by CTL is MHC class I restricted in molecules. Alternatively, exogenous antigens which do not access to the cytosol can be presented in MHC class I mice (9). As CD1d-deficient mice show equivalent susceptibility to M. tuberculosis infection as wild-type animals (7,37), it context via a non-classical pathway (32, 33) . M. tuberculosis infection facilitates the presentation of soluble antigen to appears that the presentation of mycobacterial antigens by CD1d molecules may not play an important role in protective CD8 ϩ T cells (34) . Moreover, the presentation of mycobacterial peptides to CD8 ϩ T cells is not modified by cell treatment immunity against tuberculosis in mice. This conclusion is the finding that BCG infection significantly enhanced the
